Dr. Karen E. Tye, MD

Dr. Tye practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Tye's NPI, 1225490147, was assigned on March 22, 2016. Dr. Tye graduated from University of Illinois College of Medicine - Chicago in 2016. Dr. Tye's California license number on file is A156529.

Dr. Tye's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Tye's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Tye is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Tye to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tye practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Tye's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tye is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Tye's licenses on file in 4 states: California, North Carolina, Minnesota and Illinois.

Dmand AI lists breast cancer radiation, colorectal cancer radiation, pancreatic cancer radiation and uterine cancer radiation among the conditions Dr. Tye treats.

CMS data shows 1,101 Medicare services from Dr. Tye across 16 procedure codes in 2024, for 129 Medicare patients. Medicare paid $76,620 for them. Every service was in an office.

CMS counts 129 Medicare patients who saw Dr. Tye in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have cancer, and 66% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tye's median patient age at 71, with 62% women.

In 2024, Dr. Tye wrote 195 Medicare Part D claims for 99 patients. 92% of them were for generic drugs. CMS names the drug for 117 of them, across 2 drugs with 11 or more claims each, at $1,994 in total drug cost. In 2023, CMS named 42 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tye for performance year 2024, reported as part of a group. Dr. Tye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Tye, published from 2014 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Radiation Oncology, Internship and Residency and COVID-19. Dr. Tye has published most often in Int J Radiat Oncol Biol Phys. Dr. Tye's most frequent co-authors are Shauna Rosalie Campbell, DO, Chelain Rae Goodman, MD, PhD and Elizabeth Belle Jeans, MD.

CMS Open Payments shows 5 general payments to Dr. Tye from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. GT Medical Technologies, Inc paid the most, $297.

Dr. Tye graduated from University of Illinois College of Medicine - Chicago in 2016. Dr. Tye is a member of ASTRO.

Dr. Tye is in network with 15 carriers, including Aetna, United Healthcare and Cigna. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.